The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry

被引：0

作者：

Ertenli, Ihsan ^{[1
]}

Karadag, Omer ^{[1
]}

Pehlivan, Yavuz ^{[2
]}

Dalkilic, Ediz ^{[3
]}

Onat, Ahmet Mesut ^{[4
]}

Kisacik, Bunyamin ^{[5
]}

Can, Gercek ^{[6
]}

Akar, Servet ^{[7
]}

Capar, Sedat ^{[8
]}

Kalyoncu, Umut ^{[1
]}

Oksuz, Mustafa Ferhat ^{[9
]}

Tarhan, Emine Figen ^{[7
]}

Akkoc, Nurullah ^{[6
]}

机构：

[1] Hacettepe Univ, Fac Med, Rheumatol, TR-06100 Ankara, Turkey

[2] Uludag Univ, Fac Med, Dept Rheumatol, Bursa, Turkey

[3] Uludag Univ, Fac Med, Dept Rhematol, Bursa, Turkey

[4] Gaziantep Univ, Sch Med, Rheumatol, Gaziantep, Turkey

[5] Gaziantep Univ, Sch Med, Rheumatol Dept, Gaziantep, Turkey

[6] Dokuz Eylul Univ, Fac Med, Dept Rheumatol, Izmir, Turkey

[7] Izmir Katip Celebi Univ, Div Rheumatol, Dept Internal Med, Sch Med, Izmir, Turkey

[8] Dokuz Eylul Univ, Fac Stat, Izmir, Turkey

[9] Uludag Univ, Fac Med, Rheumatol, Bursa, Turkey

来源：

ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

459

引用

页数：3

共 50 条

[1] Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry
Gottenberg, J. E.
Ravaud, P.
Cantagrel, A.
Combe, B.
Flipo, R. M.
Schaeverbeke, T.
Houvenagel, E.
Gaudin, P.
Loeuille, D.
Rist, S.
Dougados, M.
Sibilia, J.
Le Loet, X.
Marcelli, C.
Bardin, T.
Pane, I.
Baron, G.
Mariette, X.
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (11) : 1815 - 1819
[2] IS POSITIVITY OF RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ASSOCIATED WITH THE RESPONSE RATE OF INFLIXIMAB, TOCILIZUMAB, AND ABATACEPT IN TREATMENT OF RHEUMATOID ARTHRITIS?
Sato, M.
Takemura, M.
Saito, K.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 389 - 389
[3] The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
Chen, HA
Lin, KC
Chen, CH
Liao, HT
Wang, HP
Chang, HN
Tsai, CY
Chou, CT
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (01) : 35 - 39
[4] Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis
Chang, Pi-Yueh
Yang, Cheng-Tao
Cheng, Ching-Hui
Yu, Kuang-Hui
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (09) : 880 - 886
[5] Comparison of the anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis at an arthritis center
Attar, Suzan M.
Bunting, Peter S.
Smith, Charles D.
Karsh, Jacob
SAUDI MEDICAL JOURNAL, 2009, 30 (03) : 446 - 447
[6] The role of anti-cyclic citrullinated peptide and rheumatoid factor in diagnosis of rheumatoid arthritis
Cheah, Tien E.
Sockalingam, Sargunan
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2012, 15 (01) : e1 - e1
[7] Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil
Goeldner, Isabela
Skare, Thelma L.
Reason, Iara T. de Messias
Nisihara, Renato M.
Silva, Marilia B.
da Rosa Utiyama, Shirley R.
RHEUMATOLOGY, 2010, 49 (08) : 1590 - 1593
[8] DOES THE PRESENCE OF RHEUMATOID FACTOR AND/ OR ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVITY AFFECT THE MANIFESTATIONS OF RHEUMATOID ARTHRITIS?
Chan, A.
Gao, X.
See, W.
Leong, K.
Koh, E.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 988 - 989
[9] Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
Kuru, Omer
Bilgici, Ayhan
Birinci, Asuman
Ulusoy, Hasan
Durupinar, Belma
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2009, 110 (10): : 650 - 654
[10] CARDIOVASCULAR RISK, BIOLOGICS AND ANTI-CYCLIC CITRULLINATED PEPTIDE POSITIVITY IN RHEUMATOID ARTHRITIS
Jauregui, E. A.
Agudelo, C. A.
Aldana, C.
Munoz, Y. A.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1158 - 1158

← 1 2 3 4 5 →